低剂量CT肺癌筛查的辐射暴露与癌症风险:试验数据的二次分析及风险获益分析
男性第10年中位累积有效剂量9.3 mSv,女性13.0 mSv;10年筛查所致肺癌和主要癌症的终生归因风险分别为每万人5.5至1.4例和8.1至2.6例。筛查检出259例肺癌,每检出108例肺癌预期发生1例辐射诱导的主要癌症,作者认为该风险在筛查显著降低死亡率的前提下可接受。
要点
- 高危吸烟者10年低剂量CT筛查的累积辐射剂量中位数男性9.3 mSv、女性13.0 mSv。
- 10年筛查所致主要癌症终生归因风险为每万人2.6至8.1例,女性50-54岁最高。
- 每检出108例肺癌预期发生1例辐射诱导的主要癌症,风险相对获益可接受。
核心结论
- 低剂量CT肺癌筛查的辐射暴露和癌症风险虽不可忽略,但鉴于筛查带来的显著死亡率下降,可认为可接受。
研究设计与样本
- 研究纳入50岁及以上、当前或既往吸烟(≥20包年)、近5年无癌症史的高危无症状吸烟者,共5203人(男性3439人,女性1764人)。
主要发现
- 第10年筛查时中位累积有效剂量男性为9.3 mSv,女性为13.0 mSv。
- 根据年龄和性别,10年CT筛查后肺癌的终生归因风险为每万名筛查者5.5至1.4例,主要癌症为每万名筛查者8.1至2.6例。
- 50-54岁女性的肺癌和主要癌症终生归因风险分别约为65岁及以上男性的4倍和3倍。
- 10年筛查中诊断259例肺癌;队列中辐射诱导的肺癌和主要癌症病例数分别为1.5例和2.4例,对应主要癌症额外风险0.05%(2.4/5203)。
关键数值与推荐
- 每检出108例肺癌(259/2.4)预期发生1例辐射诱导的主要癌症。
- 10年筛查所致主要癌症额外风险为0.05%(2.4/5203)。
- 肺癌终生归因风险范围为每万人5.5至1.4例,主要癌症为每万人8.1至2.6例,均按年龄和性别分层。
临床怎么用
- 在全科高危吸烟人群肺癌筛查决策中,可将辐射相关癌症风险与筛查的死亡率获益共同告知患者。
- 对50-54岁女性等辐射风险较高人群,应个体化权衡筛查的获益与风险。
局限性
- 研究为非随机单中心试验的二次分析,结果外推需谨慎。
- 终生归因风险基于BEIR VII模型计算,非直接观测的辐射诱导癌症。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Objective To estimate the cumulative radiation exposure and lifetime attributable risk of cancer incidence associated with lung cancer screening using annual low dose computed tomography (CT).Design Secondary analysis of data from a lung cancer screening trial and risk-benefit analysis.Setting 10 year, non-randomised, single centre, low dose CT, lung cancer screening trial (COSMOS study) which took place in Milan, Italy in 2004-15 (enrolment in 2004-05). Secondary analysis took place in 2015-16.Participants High risk asymptomatic smokers aged 50 and older, who were current or former smokers (≥20 pack years), and had no history of cancer in the previous five years.Main outcome measures Cumulative radiation exposure from low dose CT and positron emission tomography (PET) CT scans, calculated by dosimetry software; and lifetime attributable risk of cancer incidence, calculated from the Biological Effects of Ionizing Radiation VII (BEIR VII) report.Results Over 10 years, 5203 participants (3439 men, 1764 women) underwent 42 228 low dose CT and 635 PET CT scans. The median cumulative effective dose at the 10th year of screening was 9.3 mSv for men and 13.0 mSv for women. According to participants' age and sex, the lifetime attributable risk of lung cancer and major cancers after 10 years of CT screening ranged from 5.5 to 1.4 per 10 000 people screened, and from 8.1 to 2.6 per 10 000 people screened, respectively. In women aged 50-54, the lifetime attributable risk of lung cancer and major cancers was about fourfold and threefold higher than for men aged 65 and older, respectively. The numbers of lung cancer and major cancer cases induced by 10 years of screening in our cohort were 1.5 and 2.4, respectively, which corresponded to an additional risk of induced major cancers of 0.05% (2.4/5203). 259 lung cancers were diagnosed in 10 years of screening; one radiation induced major cancer would be expected for every 108 (259/2.4) lung cancers detected through screening.Conclusion Radiation exposure and cancer risk from low dose CT screening for lung cancer, even if non-negligible, can be considered acceptable in light of the substantial mortality reduction associated with screening.
引用
- Rampinelli C, De Marco P, Origgi D, et al. Exposure to low dose computed tomography for lung cancer screening and risk of cancer: secondary analysis of trial data and risk-benefit analysis. BMJ. 2017. PMID: 28179230. doi:10.1136/bmj.j347
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。